Innate Pharma SA Share Premium
Innate Pharma SA (IPHYF) had Share Premium of EUR 408.03 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:SharePremium · last filed 2026-04-01
- 2025-12-31: Share Premium 408.03M EUR.
- 2025-06-30: Share Premium 407.05M EUR.
- 2024-12-31: Share Premium 390.98M EUR.
- 2024-06-30: Share Premium 386.05M EUR.
| Period end | Share Premium |
|---|---|
| 2025-12-31 | 408.03M EUR 20-F · filed 2026-04-01 |
| 2025-06-30 | 407.05M EUR 6-K · filed 2025-09-17 |
| 2024-12-31 | 390.98M EUR 20-F · filed 2026-04-01 |
| 2024-06-30 | 386.05M EUR 6-K · filed 2024-09-12 |
| 2023-12-31 | 384.25M EUR 20-F · filed 2026-04-01 |
| 2023-06-30 | 381.37M EUR 6-K · filed 2023-09-14 |
| 2022-12-31 | 379.64M EUR 20-F · filed 2025-04-30 |
| 2022-06-30 | 378.00M EUR 6-K · filed 2022-09-15 |
| 2021-12-31 | 375.22M EUR 20-F · filed 2024-04-04 |
| 2021-06-30 | 373.04M EUR 6-K · filed 2021-09-15 |
| 2020-12-31 | 372.13M EUR 20-F · filed 2023-04-06 |
| 2019-12-31 | 369.62M EUR 20-F · filed 2022-04-04 |
| 2018-12-31 | 299.93M EUR 20-F · filed 2021-04-27 |
| 2017-12-31 | 234.87M EUR 20-F · filed 2020-04-24 |